ARVO Annual Meeting

May 6 - 10, 2012 Fort Lauderdale, Fla.

• Abstract and travel grant recipient notifications were sent out on Jan. 31, 2012.
• Save up to $100 and register before March 23, 2012.
• Late-breaking abstracts may be submitted starting Feb. 10, 2012.

ARVO’s newest journal to examine
translational vision research

ARVO will introduce its third journal, Translational Vision Science & Technology (TVST), this spring. TVST will be an online only, peer-reviewed journal emphasizing multidisciplinary research that bridges the gap between basic research and clinical care. The TVST submission site will be open in January.

Learn more about ARVO's newest journal, including a list of the journal's editors.

Challenges in Designing Small Clinical Trials ARVO's latest Webinar is now available for purchase. See this and other 2011 webinars.

Upcoming events

	ARVO/ISIE Imaging Conference May 5, 2012, Fort Lauderdale, Fla. Abstract submission now open. Deadline Feb. 13, 2012
	Drug and Gene Delivery to the Back of the Eye: From Bench to Bedside June 15 – 16, 2012 Aurora, Colo.

• The ARVO Foundation announces the first Genentech Age-related Macular Degeneration Fellowship recipients. Read more.
• The ARVO Foundation announces the recipients of the first Vistakon Dry Eye Fellowship. Read more
• Salary caps are imposed on NIH grants, and inflationary increments are discontinued in FY 2012. Learn more.
• Funding updates
  • U.S. FY2012 vision research funding: At least $5 million more — The U.S. Congress has passed funding legislation that gives NIH a $299 million increase. This gives an additional $3.2 million to NEI. Read the details from the National Alliance for Eye and Vision Research.
  • Defense vision research cut 20% — Congress has cut the Peer Reviewed Medical Research-Vision line in defense appropriations from the FY2011 level of $4 million to $3.2 million for FY2012. However, the actual amount awarded by the Department of Defense's Telemedicine and Advanced Technology Research Center (TATRC) to vision researchers has exceeded the appropriated amount due to the quality and responsiveness of the submissions, so a final funding number will be unknown until TATRC implements the FY2012 program late this year. Read more.
• ARVO provides feedback on NIH management of resources 
• A new Journal of Vision study sheds light on how we see family resemblance in faces. Read more

ARVO is the largest and most respected eye and vision research organization in the world. Our members include more than 12,600 researchers from over 80 countries. ARVO encourages and assists research, training, publication and knowledge-sharing in vision and ophthalmology.